Document is current
Any future updates will be listed below
-
Authors
Builes-Montaño, Carlos E. https://orcid.org/0000-0002-2418-6159
Lema-Perez, Laura https://orcid.org/0000-0001-6745-3571
Ramírez-Rincón, Alex https://orcid.org/0000-0002-3925-6201
Zuleta-Tobón, John J. https://orcid.org/0000-0001-5407-7714
Restrepo-Gutiérrez, Juan C. https://orcid.org/0000-0002-7080-7956
Álvarez-Zapata, Hernán D. https://orcid.org/0000-0002-2253-3583
García-Tirado, José https://orcid.org/0000-0002-9970-2162
- License Information
-
More Information
Article History
Received: 23 May 2025
Accepted: 6 October 2025
First Online: 13 November 2025
Declarations
:
: The authors certify that they have no affiliation or are involved with any organization or entity with any financial interest (such as fees, financial aid for education, shares, employment contracts, work as consultants, or any other type of interest) or non-financial interest (such as personal, professional relationships, affiliations, or beliefs) in the topic of interest or any material discussed in this manuscript. Carlos E. Builes-Montaño has received consulting or speaker fees from Sanofi, Novo Nordisk, Novartis, and Boehringer Ingelheim. Jose Garcia-Tirado reports receiving royalties from Dexcom. All the other authors report no potential conflict of interest.
